SEI INVESTMENTS CO - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 50 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q1 2021$289,000
-6.2%
285,0000.0%0.00%0.0%
Q4 2020$308,000
+4.4%
285,0000.0%0.00%0.0%
Q3 2020$295,000
-6.1%
285,0000.0%0.00%0.0%
Q2 2020$314,000
+9.0%
285,0000.0%0.00%0.0%
Q1 2020$288,000
-11.7%
285,0000.0%0.00%0.0%
Q4 2019$326,000
+0.3%
285,0000.0%0.00%0.0%
Q3 2019$325,000
-3.6%
285,0000.0%0.00%0.0%
Q2 2019$337,000
-12.5%
285,0000.0%0.00%0.0%
Q1 2019$385,000285,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q1 2020
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 16,935,000$17,946,697,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,700,000$48,504,0002.18%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$21,312,0001.66%
LINDEN ADVISORS LP 34,494,000$36,562,0001.30%
WOLVERINE ASSET MANAGEMENT LLC 96,239,000$101,731,0001.13%
MACKAY SHIELDS LLC 24,155,000$25,567,0000.95%
Verition Fund Management LLC 10,200,000$10,799,0000.87%
Jabre Capital Partners S.A. 4,000,000$4,243,0000.82%
ADVENT CAPITAL MANAGEMENT /DE/ 38,030,000$40,330,0000.76%
AQR Arbitrage LLC 44,600,000$47,220,0000.51%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders